Lineage Cell Therapeutics Inc (LCTX): BioTime Announces Clinical and Corporate...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Lineage Cell Therapeutics Inc (LCTX)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	39
Posts	2870
Boards Moderated	0
Alias Born	12/06/2003

Re: None

Monday, 01/22/2018 9:06:35 AM

Monday, January 22, 2018 9:06:35 AM

BioTime Announces Clinical and Corporate Milestone Targets for 2018

https://tinyurl.com/y93oadok

I didn't see anything particularly new though there is evidence of continuing progress.

OpRegan's place in the constellation of therapies remains a mystery to me. As its current thrust in treating age-related therapy for dry macular degeneration, ~90% of aging related blindness for which there is no approved treatment, it would seem natural to be included in the AgeX spin-off but it hasn't been announced.

If it is to be eventually separately spun off from BTX, I have seen no mention. It looks to me like a particularly attractive spin-off in its own right in the future.

Just speculatin'.

Best, Terry

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent LCTX News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:26 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/07/2024 10:17:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:27:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:30:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:27:33 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 12:00:09 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:58:18 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 11:57:07 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:25:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:20:38 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:00:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:08:49 AM
Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies • AllPennyStocks.com • 11/16/2023 09:21:00 PM
Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies • AllPennyStocks.com • 11/16/2023 09:21:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/13/2023 09:19:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:10:32 PM
Small Company Working on Big Breakthrough in Treating Spinal Cord Injuries • AllPennyStocks.com • 10/11/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 09:01:43 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:10:12 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/27/2023 08:15:41 PM

More LCTX News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow